Atlas Trials

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Clinical trial NCT04652570 · TERMINATED

Trial details

NCT number
NCT04652570
Sponsor
Tenet Medicines
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Membranous Nephropathy
Start date
2021-05-05
Primary completion
2023-11-21
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.